全髋关节置换术后假体周围关节感染死亡率与常见癌症5年死亡率相当:一项Meta分析
术后1、3、12个月死亡率分别为1.1%、3.7%、10.0%。作者认为该死亡率与乳腺癌(11%)和前列腺癌(1%)的5年死亡率相当,需要多学科协作。
要点
- 术后12个月死亡率为10.0%,高于1个月(1.1%)和3个月(3.7%)
- 清创保留假体、一期和二期翻修术后死亡率分别为7.8%、1.6%和9.2%
核心结论
- 全髋关节置换术后假体周围关节感染死亡率高(11.0%),与乳腺癌(11%)和前列腺癌(1%)的5年死亡率相当。
- 作者认为需要采用类似癌症治疗的多学科协作方法来降低这一并发症的负担。
研究设计与样本
- 研究为Meta分析,检索六个数据库自建库至2023年12月,纳入报告初次全髋关节置换术后假体周围关节感染死亡率的全文文章。
- 排除肿瘤、感染或创伤性全髋关节置换指征的文章,以及研究高风险患者群体(包括实体器官移植、活动性癌症诊断和同期假体周围关节感染)的文章。
- 由两名独立评价者审阅文章,采用逆方差比例模型对总体死亡率进行比例Meta分析。
- 共纳入20项研究、19917例全髋关节置换术后假体周围关节感染患者。
主要发现
- 术后1、3、12个月的合并死亡率分别为1.1%、3.7%和10.0%。
- 清创、抗生素和假体保留术后死亡率为7.8%(95%CI:2.3-15.9)。
- 一期翻修术后死亡率为1.6%(95%CI:0-14),二期翻修术后死亡率为9.2%(95%CI:5.4-13.9)。
- 存在相当大的异质性。
临床怎么用
- 作者认为需要采用类似癌症治疗的多学科协作方法来降低这一并发症的负担。
局限性
- 存在相当大的异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic joint infection (PJI) after total hip arthroplasty (THA) is a rare, but devastating complication with elevated morbidity and mortality. While associated with increased mortality, the reported range is broad and most often reported after 2-stage exchange arthroplasty. This study aimed to report the overall mortality after PJI following primary THA, PJI mortality at one, three, and 12 months, and mortality after common PJI treatments. We hypothesized that mortality after THA PJI would be high, increase over time, and be highest after a 2-stage exchange. METHODS: A meta-analysis of articles from six databases, queried from inception to December 2023, was performed. Full-length articles reporting mortality following PJI after primary THA were included. Articles with oncologic, infectious, or traumatic THA indications were excluded. Articles investigating high-risk patient populations, including those who had solid organ transplants, active cancer diagnoses, and synchronous PJI, were excluded. There were two independent reviewers who reviewed articles. Mortality over time and after treatment (debridement, antibiotics, and implant retention, 1-stage, and 2-stage exchange arthroplasty) was collected. A meta-analysis of proportions with inverse-variance proportion models was constructed for overall mortality. RESULTS: A total of 19,917 patients who had PJI after THA from 20 studies were included. Overall mortality was 11.0% (95% CI [confidence interval]: five to 18.8) at a mean follow-up of 40.3 months (range, one to 240). Pooled mortality at one, three, and 12 months was 1.1, 3.7, and 10.0%, respectively. Mortality following treatment with debridement, antibiotics, and implant retention, 1-stage, and 2-stage exchange was 7.8% (95% CI: 2.3 to 15.9), 1.6% (95% CI: 0 to 14), and 9.2% (95% CI: 5.4 to 13.9), respectively. Considerable heterogeneity was present. CONCLUSIONS: Mortality after THA PJI is high (11.0%) within three years of arthroplasty and comparable to 5-year rates of cancers, such as breast (11%) and prostate (1%) cancers. A multidisciplinary approach, like those adopted in the treatment of cancer, is warranted to reduce the burden of this devastating complication.
引用
- Ramos MS, Benyamini B, Kompala V, et al. Periprosthetic Joint Infection Mortality After Total Hip Arthroplasty Is Comparable to 5-Year Rates of Common Cancers: A Meta-Analysis. J Arthroplasty. 2025. PMID: 40311946. doi:10.1016/j.arth.2025.04.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。